Global Metabotropic Glutamate Receptor 5 Market Professional Survey Report 2019
Table of Contents
Executive Summary
1 Industry Overview of Metabotropic Glutamate Receptor 5
- 1.1 Definition of Metabotropic Glutamate Receptor 5
- 1.2 Metabotropic Glutamate Receptor 5 Segment by Type
- 1.2.1 Global Metabotropic Glutamate Receptor 5 Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Alloswitch-1
- 1.2.3 BMS-952048
- 1.2.4 BMS-955829
- 1.2.5 Dipraglurant ER
- 1.2.6 Others
- 1.3 Metabotropic Glutamate Receptor 5 Segment by Applications
- 1.3.1 Global Metabotropic Glutamate Receptor 5 Consumption Comparison by Applications (2014-2025)
- 1.3.2 Major Depressive Disorder
- 1.3.3 Alcohol Assiction
- 1.3.4 Alzheimer's Disease
- 1.3.5 Others
- 1.4 Global Metabotropic Glutamate Receptor 5 Overall Market
- 1.4.1 Global Metabotropic Glutamate Receptor 5 Revenue (2014-2025)
- 1.4.2 Global Metabotropic Glutamate Receptor 5 Production (2014-2025)
- 1.4.3 North America Metabotropic Glutamate Receptor 5 Status and Prospect (2014-2025)
- 1.4.4 Europe Metabotropic Glutamate Receptor 5 Status and Prospect (2014-2025)
- 1.4.5 China Metabotropic Glutamate Receptor 5 Status and Prospect (2014-2025)
- 1.4.6 Japan Metabotropic Glutamate Receptor 5 Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Metabotropic Glutamate Receptor 5 Status and Prospect (2014-2025)
- 1.4.8 India Metabotropic Glutamate Receptor 5 Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Metabotropic Glutamate Receptor 5
- 2.3 Manufacturing Process Analysis of Metabotropic Glutamate Receptor 5
- 2.4 Industry Chain Structure of Metabotropic Glutamate Receptor 5
3 Development and Manufacturing Plants Analysis of Metabotropic Glutamate Receptor 5
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Metabotropic Glutamate Receptor 5 Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Metabotropic Glutamate Receptor 5
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Metabotropic Glutamate Receptor 5 Production and Capacity Analysis
- 4.2 Metabotropic Glutamate Receptor 5 Revenue Analysis
- 4.3 Metabotropic Glutamate Receptor 5 Price Analysis
- 4.4 Market Concentration Degree
5 Metabotropic Glutamate Receptor 5 Regional Market Analysis
- 5.1 Metabotropic Glutamate Receptor 5 Production by Regions
- 5.1.1 Global Metabotropic Glutamate Receptor 5 Production by Regions
- 5.1.2 Global Metabotropic Glutamate Receptor 5 Revenue by Regions
- 5.2 Metabotropic Glutamate Receptor 5 Consumption by Regions
- 5.3 North America Metabotropic Glutamate Receptor 5 Market Analysis
- 5.3.1 North America Metabotropic Glutamate Receptor 5 Production
- 5.3.2 North America Metabotropic Glutamate Receptor 5 Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Metabotropic Glutamate Receptor 5 Import and Export
- 5.4 Europe Metabotropic Glutamate Receptor 5 Market Analysis
- 5.4.1 Europe Metabotropic Glutamate Receptor 5 Production
- 5.4.2 Europe Metabotropic Glutamate Receptor 5 Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Metabotropic Glutamate Receptor 5 Import and Export
- 5.5 China Metabotropic Glutamate Receptor 5 Market Analysis
- 5.5.1 China Metabotropic Glutamate Receptor 5 Production
- 5.5.2 China Metabotropic Glutamate Receptor 5 Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Metabotropic Glutamate Receptor 5 Import and Export
- 5.6 Japan Metabotropic Glutamate Receptor 5 Market Analysis
- 5.6.1 Japan Metabotropic Glutamate Receptor 5 Production
- 5.6.2 Japan Metabotropic Glutamate Receptor 5 Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Metabotropic Glutamate Receptor 5 Import and Export
- 5.7 Southeast Asia Metabotropic Glutamate Receptor 5 Market Analysis
- 5.7.1 Southeast Asia Metabotropic Glutamate Receptor 5 Production
- 5.7.2 Southeast Asia Metabotropic Glutamate Receptor 5 Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Metabotropic Glutamate Receptor 5 Import and Export
- 5.8 India Metabotropic Glutamate Receptor 5 Market Analysis
- 5.8.1 India Metabotropic Glutamate Receptor 5 Production
- 5.8.2 India Metabotropic Glutamate Receptor 5 Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Metabotropic Glutamate Receptor 5 Import and Export
6 Metabotropic Glutamate Receptor 5 Segment Market Analysis (by Type)
- 6.1 Global Metabotropic Glutamate Receptor 5 Production by Type
- 6.2 Global Metabotropic Glutamate Receptor 5 Revenue by Type
- 6.3 Metabotropic Glutamate Receptor 5 Price by Type
7 Metabotropic Glutamate Receptor 5 Segment Market Analysis (by Application)
- 7.1 Global Metabotropic Glutamate Receptor 5 Consumption by Application
- 7.2 Global Metabotropic Glutamate Receptor 5 Consumption Market Share by Application (2014-2019)
8 Metabotropic Glutamate Receptor 5 Major Manufacturers Analysis
- 8.1 Addex Therapeutics Ltd
- 8.1.1 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Production Sites and Area Served
- 8.1.2 Addex Therapeutics Ltd Product Introduction, Application and Specification
- 8.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Aevi Genomic Medicine Inc
- 8.2.1 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Production Sites and Area Served
- 8.2.2 Aevi Genomic Medicine Inc Product Introduction, Application and Specification
- 8.2.3 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Bristol-Myers Squibb Company
- 8.3.1 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Production Sites and Area Served
- 8.3.2 Bristol-Myers Squibb Company Product Introduction, Application and Specification
- 8.3.3 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Eisai Co Ltd
- 8.4.1 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Production Sites and Area Served
- 8.4.2 Eisai Co Ltd Product Introduction, Application and Specification
- 8.4.3 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Eli Lilly and Company
- 8.5.1 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Production Sites and Area Served
- 8.5.2 Eli Lilly and Company Product Introduction, Application and Specification
- 8.5.3 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Heptares Therapeutics Ltd
- 8.6.1 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Production Sites and Area Served
- 8.6.2 Heptares Therapeutics Ltd Product Introduction, Application and Specification
- 8.6.3 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Johnson & Johnson
- 8.7.1 Johnson & Johnson Metabotropic Glutamate Receptor 5 Production Sites and Area Served
- 8.7.2 Johnson & Johnson Product Introduction, Application and Specification
- 8.7.3 Johnson & Johnson Metabotropic Glutamate Receptor 5 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Merz Pharma GmbH & Co KgaA
- 8.8.1 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Production Sites and Area Served
- 8.8.2 Merz Pharma GmbH & Co KgaA Product Introduction, Application and Specification
- 8.8.3 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Novartis AG
- 8.9.1 Novartis AG Metabotropic Glutamate Receptor 5 Production Sites and Area Served
- 8.9.2 Novartis AG Product Introduction, Application and Specification
- 8.9.3 Novartis AG Metabotropic Glutamate Receptor 5 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Richter Gedeon Nyrt
- 8.10.1 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Production Sites and Area Served
- 8.10.2 Richter Gedeon Nyrt Product Introduction, Application and Specification
- 8.10.3 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 Sumitomo Dainippon Pharma Co Ltd
- 8.12 Toray Industries Inc
9 Development Trend of Analysis of Metabotropic Glutamate Receptor 5 Market
- 9.1 Global Metabotropic Glutamate Receptor 5 Market Trend Analysis
- 9.1.1 Global Metabotropic Glutamate Receptor 5 Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Metabotropic Glutamate Receptor 5 Regional Market Trend
- 9.2.1 North America Metabotropic Glutamate Receptor 5 Forecast 2019-2025
- 9.2.2 Europe Metabotropic Glutamate Receptor 5 Forecast 2019-2025
- 9.2.3 China Metabotropic Glutamate Receptor 5 Forecast 2019-2025
- 9.2.4 Japan Metabotropic Glutamate Receptor 5 Forecast 2019-2025
- 9.2.5 Southeast Asia Metabotropic Glutamate Receptor 5 Forecast 2019-2025
- 9.2.6 India Metabotropic Glutamate Receptor 5 Forecast 2019-2025
- 9.3 Metabotropic Glutamate Receptor 5 Market Trend (Product Type)
- 9.4 Metabotropic Glutamate Receptor 5 Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Metabotropic Glutamate Receptor 5 Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
The global Metabotropic Glutamate Receptor 5 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Metabotropic Glutamate Receptor 5 volume and value at global level, regional level and company level. From a global perspective, this report represents overall Metabotropic Glutamate Receptor 5 market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Metabotropic Glutamate Receptor 5 in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Metabotropic Glutamate Receptor 5 manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Addex Therapeutics Ltd
Aevi Genomic Medicine Inc
Bristol-Myers Squibb Company
Eisai Co Ltd
Eli Lilly and Company
Heptares Therapeutics Ltd
Johnson & Johnson
Merz Pharma GmbH & Co KgaA
Novartis AG
Richter Gedeon Nyrt
Sumitomo Dainippon Pharma Co Ltd
Toray Industries Inc
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Alloswitch-1
BMS-952048
BMS-955829
Dipraglurant ER
Others
Segment by Application
Major Depressive Disorder
Alcohol Assiction
Alzheimer's Disease
Others